BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 9380727)

  • 1. Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia.
    Becker KJ; McCarron RM; Ruetzler C; Laban O; Sternberg E; Flanders KC; Hallenbeck JM
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10873-8. PubMed ID: 9380727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: a role for lymphocytes in ischemic brain injury?
    Becker K; Kindrick D; McCarron R; Hallenbeck J; Winn R
    Stroke; 2003 Jul; 34(7):1809-15. PubMed ID: 12791945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke.
    Gee JM; Kalil A; Thullbery M; Becker KJ
    Stroke; 2008 May; 39(5):1575-82. PubMed ID: 18323496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.
    Khoury SJ; Hancock WW; Weiner HL
    J Exp Med; 1992 Nov; 176(5):1355-64. PubMed ID: 1383385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.
    Miller A; Lider O; Roberts AB; Sporn MB; Weiner HL
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):421-5. PubMed ID: 1370356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animals.
    Miller A; Lider O; Abramsky O; Weiner HL
    Eur J Immunol; 1994 May; 24(5):1026-32. PubMed ID: 7514126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
    Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
    Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization.
    Miller A; Zhang ZJ; Sobel RA; al-Sabbagh A; Weiner HL
    J Neuroimmunol; 1993 Jul; 46(1-2):73-82. PubMed ID: 7689596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression.
    Miller A; al-Sabbagh A; Santos LM; Das MP; Weiner HL
    J Immunol; 1993 Dec; 151(12):7307-15. PubMed ID: 7505026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA.
    Bai XF; Shi FD; Xiao BG; Li HL; van der Meide PH; Link H
    J Neuroimmunol; 1997 Dec; 80(1-2):65-75. PubMed ID: 9413260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen.
    al-Sabbagh A; Nelson PA; Akselband Y; Sobel RA; Weiner HL
    Cell Immunol; 1996 Jul; 171(1):111-9. PubMed ID: 8660845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal cord neuropathology in rat experimental autoimmune encephalomyelitis: modulation by oral administration of myelin basic protein.
    Popovich PG; Yu JY; Whitacre CC
    J Neuropathol Exp Neurol; 1997 Dec; 56(12):1323-38. PubMed ID: 9413281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.
    Fukaura H; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Hafler DA
    J Clin Invest; 1996 Jul; 98(1):70-7. PubMed ID: 8690806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
    Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats.
    Li HL; Liu JQ; Bai XF; vn der Meide PH; Link H
    Immunology; 1998 Jul; 94(3):431-7. PubMed ID: 9767428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of mucosal tolerance to E-selectin prevents ischemic and hemorrhagic stroke in spontaneously hypertensive genetically stroke-prone rats.
    Takeda H; Spatz M; Ruetzler C; McCarron R; Becker K; Hallenbeck J
    Stroke; 2002 Sep; 33(9):2156-63. PubMed ID: 12215580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral tolerance to copolymer 1 in myelin basic protein (MBP) TCR transgenic mice: cross-reactivity with MBP-specific TCR and differential induction of anti-inflammatory cytokines.
    Maron R; Slavin AJ; Hoffmann E; Komagata Y; Weiner HL
    Int Immunol; 2002 Feb; 14(2):131-8. PubMed ID: 11809732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide.
    Khoury SJ; Lider O; al-Sabbagh A; Weiner HL
    Cell Immunol; 1990 Dec; 131(2):302-10. PubMed ID: 1700738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein.
    Bitar DM; Whitacre CC
    Cell Immunol; 1988 Apr; 112(2):364-70. PubMed ID: 2451570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal cerebral ischemia induces increased myelin basic protein and growth-associated protein-43 gene transcription in peri-infarct areas in the rat brain.
    Gregersen R; Christensen T; Lehrmann E; Diemer NH; Finsen B
    Exp Brain Res; 2001 Jun; 138(3):384-92. PubMed ID: 11460777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.